Table 2 Knowledge of reproductive-age women in Alexandria about TTV and MNT, 2018
Knowledge (n = 700) | Percent |
|---|---|
Number of doses during the reproductive age* | |
1 dose | 0.1 |
2 doses | 2.9 |
3 doses | 3.5 |
4 doses | 0.3 |
5 doses | 3.6 |
Do not know | 89.6 |
Person(s) protected by TTV | |
Mother | 21.5 |
Child | 7.0 |
Mother and child | 37.9 |
Do not know | 33.6 |
TTV protects from | |
Diphtheria | 0.7 |
Puerperal sepsis | 10.6 |
Maternal and neonatal tetanus | 8.9 |
Toxoplasmosis | 0.3 |
Infection during delivery | 47.1 |
Pre-eclampsia | 0.4 |
Premature labor | 1.9 |
Prevent congenital anomalies | 0.9 |
Jaundice after delivery | 0.3 |
Do not know | 28.9 |
Causes of maternal and neonatal tetanus | |
Premature labor | 1.1 |
Cutting umbilical cord by contaminated or rusted instruments | 13.0 |
Delivery or abortion in un equipped places | 15.2 |
Gestational diabetes | 0.4 |
Do not know | 70.3 |
Symptoms of maternal and neonatal tetanus | |
Fever | 3.6 |
Convulsions | 0.6 |
Difficulty swallowing | 0.2 |
Vomiting and diarrhea | 1.0 |
All of above | 5.4 |
Symptoms of MNT (cont’d) | |
Other | 1.6 |
Do not know | 87.6 |
Complications of tetanus | |
Maternal and neonatal death | 5.6 |
Do not know | 94.4 |
Methods of tetanus prevention | |
Vaccination | 11.1 |
Delivery in equipped places | 16.2 |
Do not know | 72.7 |